Triptans are also serotonin agonists that work on the 5HT1B and 5HT1D receptors and concomitant use with SSRI/SNRI has a small chance of leading to serotonin syndrome which is unsubstantiated in clinical practice (62). Here, HTR1B is linked to serotonin syndrome.